Trials / Terminated
TerminatedNCT05878652
Playmaker 3D Printed Knee Extender
Utilization of a 3D Printed Customized Knee Extender on Patient Outcomes Following ACL Injuries
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Sanford Health · Academic / Other
- Sex
- All
- Age
- 14 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to explore the development of, and patient outcomes associated with, the use of individually printed knee extender in conjunction with a video-based home pre-habilitation program for patients who have suffered an ACL rupture before surgery.
Detailed description
The proposed study will assess the efficacy of utilizing desktop 3DP for patient-specific knee extenders paired with a video-based home pre-habilitation program to address the aforementioned barriers. If the novel device and home program is found to be a viable treatment option, this may improve or replace current treatments for knee pre-habilitation, increase accessibility to proper treatment, and reduce cost and time burden on patients, PTs, and providers. The study will offer a greater understanding of potential improvements to clinical workflows and efficiencies through using 3DP. This technology is an under- utilized resource; further research into the applications of 3DP in the field of orthopaedics will provide opportunities to improve patient care and outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 3D printed knee extender device | Participants will receive the standard of prehabilitation education at Sanford as well as a 3D printed knee extension device with sealed water bottles and a home prehabilitation program designed to be used with the 3D printed knee extension device. |
| OTHER | Standard Prehabilitation Education | Participants in the control group will receive the standard prehabilitation education at Sanford and provided exercises to do at home. |
Timeline
- Start date
- 2022-06-15
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2023-05-26
- Last updated
- 2024-03-08
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05878652. Inclusion in this directory is not an endorsement.